Effects of hydrocortisone and yohimbine on selective attention to emotional cues.
Adolescent
Adrenergic alpha-2 Receptor Antagonists
/ administration & dosage
Adult
Attentional Bias
/ drug effects
Cues
Double-Blind Method
Emotions
/ drug effects
Facial Recognition
/ drug effects
Glucocorticoids
/ administration & dosage
Humans
Hydrocortisone
/ administration & dosage
Hypothalamo-Hypophyseal System
/ drug effects
Male
Pituitary-Adrenal System
/ drug effects
Salivary alpha-Amylases
/ metabolism
Yohimbine
/ administration & dosage
Young Adult
Stress
attentional bias
dot-probe task
hydrocortisone
yohimbine
Journal
Journal of psychopharmacology (Oxford, England)
ISSN: 1461-7285
Titre abrégé: J Psychopharmacol
Pays: United States
ID NLM: 8907828
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
pubmed:
30
3
2021
medline:
27
1
2022
entrez:
29
3
2021
Statut:
ppublish
Résumé
Facial expressions contain important affective information, and selective attention to facial expression provides an advantage in the face of loss, stress and danger. In addition, the sympathetic nervous system and hypothalamus-pituitary-adrenal axis mediate the organism's response to loss and danger. Here, we aimed at investigating the influence of sympathetic nervous system and hypothalamus-pituitary-adrenal axis activation on selective attention to affective facial stimuli. One hundred-and-four healthy men between 18-35 years old (mean (standard deviation) age: 24.1 (3.5) years) participated in the study. We used a randomised, double-blind, placebo-controlled design. Participants received either: (a) yohimbine, (b) hydrocortisone, (c) yohimbine and hydrocortisone or (d) placebo only and participated in a dot-probe task with sad, happy and neutral faces. We collected salivary samples to measure cortisol and alpha amylase activity in addition to measurements of blood pressure and heart rate. Salivary cortisol served as correlate of hypothalamus-pituitary-adrenal axis activation and salivary alpha amylase activity, blood pressure and heart rate as correlates of sympathetic nervous system activation. Measurements were carried out before and after drug administration. We did not find a main effect or interaction effect of hydrocortisone or yohimbine administration on selective attention to happy faces. However, we found an interaction of yohimbine and hydrocortisone on selective attention to sad faces. Post-hoc Only hydrocortisone administration led to an attentional bias away from sad faces. Future studies should investigate these effects in major depression disorder, as this disorder is characterised by glucocorticoid resistance and increased processing of sad stimuli.
Identifiants
pubmed: 33779376
doi: 10.1177/0269881121997100
pmc: PMC8278549
doi:
Substances chimiques
Adrenergic alpha-2 Receptor Antagonists
0
Glucocorticoids
0
Yohimbine
2Y49VWD90Q
Salivary alpha-Amylases
EC 3.2.1.1
Hydrocortisone
WI4X0X7BPJ
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
755-759Références
Psychopharmacology (Berl). 2016 Sep;233(18):3405-15
pubmed: 27422567
Psychopharmacology (Berl). 2011 May;215(1):71-9
pubmed: 21161185
Dev Psychopathol. 2009 Winter;21(1):69-85
pubmed: 19144223
Psychopharmacology (Berl). 2009 Jun;204(3):445-55
pubmed: 19266185
Sci Rep. 2017 Nov 6;7(1):14607
pubmed: 29097660
J Psychiatr Res. 2020 Jun;125:136-143
pubmed: 32283407
Eur Neuropsychopharmacol. 2017 Jun;27(6):554-559
pubmed: 28479211
Psychoneuroendocrinology. 2007 Aug;32(7):793-802
pubmed: 17604912
Behav Res Methods. 2010 Feb;42(1):351-62
pubmed: 20160315
Biol Psychol. 2007 Apr;75(1):1-7
pubmed: 17030399
Life Sci. 1996;58(17):1475-83
pubmed: 8622574
Clin Neurophysiol. 2016 Dec;127(12):3552-3560
pubmed: 27833064
Psychoneuroendocrinology. 2020 Apr;114:104589
pubmed: 32028083
Psychophysiology. 2003 Mar;40(2):167-73
pubmed: 12820857
Behav Brain Res. 2019 Nov 5;373:112072
pubmed: 31279794
Soc Cogn Affect Neurosci. 2014 Dec;9(12):2067-77
pubmed: 24532703
Psychoneuroendocrinology. 2013 Dec;38(12):3167-71
pubmed: 24099860
Front Endocrinol (Lausanne). 2020 Jun 02;11:311
pubmed: 32582024
Neuropsychopharmacology. 2013 Apr;38(5):826-45
pubmed: 23303057